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Abstract
Cells differentiate when transcription factors (TFs) bind accessible cis-regulatory elements to
establish specific gene expression programs. In differentiating embryonic stem (ES) cells,
chromatin at lineage-restricted genes becomes sequentially accessible1-4, probably by virtue of
“pioneer” TF activity5, but tissues may utilize other strategies in vivo. Lateral inhibition is a
pervasive process in which one cell forces a different identity on its neighbors6, and it is unclear
how chromatin in equipotent progenitors undergoing lateral inhibition quickly enables distinct,
transiently reversible cell fates. Here we report the chromatin and transcriptional underpinnings of
differentiation in mouse small intestine crypts, where Notch signaling mediates lateral inhibition
to assign progenitor cells into absorptive or secretory lineages7-9. Transcript profiles in isolated
LGR5+ intestinal stem cells (ISC)10 and secretory and absorptive progenitors indicated that each
cell population was distinct and the progenitors specified. Nevertheless, secretory and absorptive
progenitors showed comparable levels of H3K4me2 and H3K27ac histone marks and DNaseI
hypersensitivity - signifying accessible, permissive chromatin - at most of the same cis-elements.
Enhancers acting uniquely in progenitors were well-demarcated in LGR5+ ISC, revealing early
priming of chromatin for divergent transcriptional programs, and retained active marks well after
lineages were specified. On this chromatin background, ATOH1, a secretory-specific TF, controls
lateral inhibition through Delta-like Notch ligand genes and also drives numerous secretory
lineage genes. Depletion of ATOH1 from specified secretory cells converted them into functional
enterocytes, indicating prolonged responsiveness of marked enhancers to presence or absence of a
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tkey TF. Thus, lateral inhibition and intestinal crypt lineage plasticity involve interaction of a
lineage-restricted TF with broadly permissive chromatin established in multipotent stem cells.
Keywords
Tissue differentiation; intestinal crypts; Notch signaling; ATOH1; Lgr5 stem cells
Intestinal crypts produce enterocyte (ENT) and secretory (enteroendocrine, goblet – GOB –
or Paneth) lineages after bipotential progenitors start to express ATOH1 and Delta-like
ligands, which activate Notch receptors on adjacent cells8,9. Notch signaling silences Atoh1
in recipient cells and within 6 hr ATOH1+ cells adopt the secretory fate, whereas ATOH1−
cells become enterocytes9,11,12 (Extended Data Fig. 1a); forced ATOH1 expression in
mouse fetal intestines promotes secretory differentiation13. To investigate the chromatin
basis for ATOH1's deterministic activity in lateral inhibition, we purified workhorse LGR5+
ISC from Lgr5GFP-Cre mouse crypts10 (Extended Data Fig. 1b-c). Exploiting a total absence
of secretory cells in Atoh1−/− intestines11,12,14 (Extended Data Fig. 1d-e), we also harvested
mature villus ENT (Fig. 1f) and their crypt progenitors (Ent-Pro, Fig. 1l) from Villin-
CreER;AtohFl/Fl mice (Extended Data Table 1). To expand Sec-Pro, we separately depleted
transcription factor RBPJ, which mediates Notch responses6,7, or disrupted Notch signaling
with the γ-secretase inhibitor dibenzazepine (DBZ)7,15. Both approaches induced replication
arrest and an excess of all secretory cell types12,16 (Figs. 1e and 1q; Extended Data Figs. 1f
and 2). Four days after induced Rbpj deletion or 72 h after administration of DBZ, secretory
cells appeared in all crypts, but not yet on villi (Fig. 1d, Extended Data Fig. 2), revealing
their origins in Sec-Pro. Accordingly, 1 day (Rbpj−/−) or 1.5 day (DBZ) earlier, crypts
uniformly showed high ATOH1 expression, ongoing cell replication, and negligible avidity
for the goblet cell (GOB) stain Alcian blue (Figs. 1b-c, 1h-i, 1n-o). Confirming that these
ATOH1+ cells are bona fide Sec-Pro, they robustly expressed known secretory genes17 (e.g.,
Neurog3, Gfi1, Spdef); moreover, Sec-Pro produced in different ways had similar expression
profiles, distinct from characteristic transcripts enriched in other cell populations (Extended
Data Fig. 3; Supplementary Information Table 1). Although LGR5+ ISC, Sec-Pro, and Ent-
Pro share many transcripts, the divergent cell sources and expression profiles indicate that
they represent discrete, specified crypt populations.
We used chromatin immunoprecipitation with deep sequencing (ChIP-seq) to first identify
sites carrying H3K4me2, a robust mark of functional cis-element activity18,19. As
mammalian genes are controlled mainly through distant enhancers20, where tissue-restricted
TFs bind DNA21, we concentrated on regions >2 kb upstream or >1 kb downstream of
transcription start sites (TSSs). Highly concordant enhancer profiles in independent Ent-Pro
replicates and in Sec-Pro obtained after genetic or chemical Notch inhibition (Fig. 2a-b;
Extended Data Fig. 4) gave confidence in epigenome analysis of primary cells. As
prevailing concepts predict, villus cells clustered farthest in aggregate analysis of
H3K4me2-marked enhancers (Fig. 2b) because many enhancers were marked in mature
ENT and GOB, but not in their progenitors (Group 2 in Fig. 2a; Extended Data Fig. 5a);
these enhancers, delineated only in mature cells, showed significant TF motif enrichment
(Supplementary Information Table 2). To our surprise, not only were many enhancers
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tprominently marked in progenitor cells, but H3K4me2 showed strikingly similar
distributions in Sec-Pro and Ent-Pro (Group 1 in Fig. 2a; Extended Data Fig. 5b). Marks
were evident at these sites even in LGR5+ ISC, distinct from the Group 2 profile, and
aggregate analysis verified significant overlap of H3K4me2 enhancers among crypt
populations (Fig. 2b). Sites that seemed superficially better marked in DBZ-derived Sec-Pro
(Group 1b) lacked TF motif enrichment or other distinguishing features and Sec-Pro-
restricted genes were not enriched near these sites but distributed among enhancers marked
in all 3 crypt populations (Fig. 2a and Supplementary Information Tables 1 and 2).
As H3K4 is methylated at both poised and active cis-elements in ES cells1, the striking
overlap in progenitor cell marks might reflect enhancer potential, distinct from enhancer
activity; H3K27ac is thought to mark active enhancers specifically22,23. Though many
H3K4me2-marked enhancers lacked H3K27ac, global and local distributions of the latter
were remarkably similar in Sec-Pro and Ent-Pro (Fig. 2c-d). DNaseI-hypersensitivity (DHS
- an independent, direct measure of chromatin access)24 was evident at most H3K4me2 sites
and its distribution also highly similar in Sec-Pro and Ent-Pro (Fig. 2c-d), distinct from DHS
in other mouse tissues (Extended Data Fig. 5c). Thus, thousands of enhancers for lineage-
restricted genes show comparable histone activation and tissue-specific chromatin access in
distinct, specified crypt progenitors and most such sites carry H3K4me2 in ISC. This early,
indiscriminate delineation of enhancers offers a compelling explanation for crypt cell
equipotency, a key feature of lateral inhibition, and reveals that intestinal lineage separation
does not require differential chromatin priming in daughter cells and may instead rely
principally on TF activity.
ATOH1, a Sec-Pro-specific TF, is an ideal candidate to confer selectivity (Extended data
Fig. 6a). FLAG ChIP-seq in Sec-Pro isolated from Atoh1Flag mice25 identified thousands of
binding sites, most of them in highly conserved, distant enhancers carrying ATOH1
consensus motifs (Extended Data Figs. 4b, 6b) and different from ATOH1 binding sites in
cerebellar neurons25 (Fig. 3a). Intestinal and neuronal binding sites coincided with tissue-
specific H3K4 methylation (Extended Data Fig. 6c), attesting to the regulatory significance
of this histone modification. Lateral inhibition requires Atoh1 repression in Notch-recipient
cells and ATOH1 activity in Sec-Pro12,14, and the rapidity of ATOH1-induced lineage
divergence9 hints that it may directly regulate genes driving lateral inhibition. Indeed,
ATOH1 bound strongly to its own locus and those for Notch ligands Dll1 and Dll4 (Fig. 3b),
but not Ent-Pro-specific loci such as Bcl215 (Extended Data Fig. 6d). These findings support
a cell-intrinsic, ATOH1-dependent mechanism for lateral inhibition and a simple, direct
means for feed-forward maintenance of this bistable system26. ATOH1 also bound
numerous loci implicated in secretory differentiation, including determinants of each sub-
lineage, and the corresponding transcripts are low or absent in Atoh1−/− crypts (Fig. 3b;
Extended Data Fig. 6e-f). Strong, specific association of ATOH1 binding with Sec-Pro-
restricted transcripts further implies that it activates secretory genes without binding or
directly repressing ENT genes (Extended Data Fig. 6g).
H3K4me2, H3K27ac, and DHS signals at ATOH1-bound enhancers were, on average,
equally strong in ATOH1+ Sec-Pro and Ent-Pro, which categorically lack ATOH1 (Fig. 3c).
Few secretory loci showed modestly stronger features in Sec-Pro or GOB (Extended Data
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tFig. 5d), but most profiles were similar in LGR5+ ISC and both progenitors (Fig. 3d).
Although in villus cells ATOH1 preferred sites marked only in GOB over those marked only
in ENT, in crypts it overwhelmingly favored enhancers bearing H3K4me2 in all populations
(Extended Data Fig. 7). The pervasive demarcation of ATOH1-bound enhancers in Atoh1−/−
Ent-Pro reveals that this TF does not initiate or maintain chromatin access in crypt cells.
The extreme overlap of Sec-Pro and Ent-Pro enhancer profiles indicates persistence of cis-
element marks after lineage specification. Intestinal lineages might therefore remain plastic
beyond the period of lateral inhibition and sustained chromatin access might explain why
some differentiated crypt cells readily assume stem-cell properties17,27,28. Our findings
particularly suggest that chromatin in specified cells may stay responsive to presence or
absence of ATOH1. In Atoh1-null fetal intestines, an Atoh1LacZ allele is expressed in
ENT14, but this finding could represent a non-cell-autonomous effect of abortive lateral
inhibition. We postulated prolonged, cell-autonomous ATOH1 control of lineage identity in
specified cells.
To test this hypothesis, we suppressed Notch in Atoh1Fl/Fl;Villin-CreER mice and waited
past the period of widespread Sec-Pro differentiation before administering tamoxifen to
induce Atoh1 deletion; we also injected bromodeoxyuridine (BrdU) to monitor cell
replication and turnover (Fig. 4a). Crypts and villus bases in control Atoh1Fl/Fl;Cre− mice
became filled with non-replicating GOB 3 days after Notch inhibition, as expected (Fig. 4b-
d), whereas ATOH1-depleted crypts showed substantial proliferation and many fewer
Alcian blue-avid cells (Fig. 4e-g). To demonstrate that this marked difference from control
mice did not represent rescue by a few ISC that might have eluded Notch inhibition but
rather secretory cell conversion to ENT, we followed cells for 3 additional days (Fig. 4a).
By this time Notch-inhibited control Atoh1Fl/Fl;Cre− mice became moribund and had short
villi containing only GOB that showed no BrdU labeling (Fig. 4h-k). Meanwhile, in the
absence of Notch suppression, BrdU tracer in wild-type or Atoh1−/− intestines had moved
from crypts into villus tips (Extended Data Fig. 8a-d), as expected. Atoh1Fl/Fl;VillinCre-ER
mice remained fit and carried only alkaline phosphatase (ALPI)-expressing ENT on tall villi
with abundant BrdU signal at the tips (Fig. 4l-o). Thus, ATOH1 loss had overcome secretory
fate and replication arrest more than 2 days after Notch inhibition to become Ent-Pro that
proliferated and matured into functional ENT.
To verify cell-autonomous fate conversion, we used progesterone/RU486-responsive
Atoh1Cre-PR mice29. Following RU486 injection, YFP signals in control
Atoh1Cre-PR/+;Rosa26YFP mice were confined to few GOB and enteroendocrine cells,
indicating weak but restricted Cre activity; 4 independent mice never labeled ENT or cell
stripes, crucially confirming absence of leaky Cre activity in ISC or multipotent progenitors
(Extended Data Fig. 8e-f). We suppressed Notch in Atoh1Cre-PR/Fl;Rosa26YFP mice, then
activated Cre selectively in ATOH1+ secretory cells, thus deleting the floxed Atoh1 allele
and simultaneously activating a fluorescent lineage tracer (Fig. 4p). Four days later, stripes
of YFP+ cells emanated from crypts and 95% ± s.d.4.1% of YFP+ ATOH1-depleted cells
(N=1,200 cells; 4 mice) in these ribbons lacked the GOB marker TFF3 but expressed ALPI
(Fig 4q-s; Extended Data Fig. 8g), confirming bona fide conversion of secretory cells to
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tENT. Thus, specified secretory cells are not irrevocably committed and their switched
identity upon ATOH1 withdrawal mirrors the broadly permissive chromatin in crypt cells.
Mathematical modeling suggests that bifurcating valleys in Waddington's famous epigenetic
landscape best represent reversible nodes, a hallmark of lateral inhibition26. The broad
priming of ISC and progenitor cell enhancers offers a satisfying explanation for this property
in intestinal crypts and accounts for ATOH1 activity in both lateral inhibition and secretory
differentiation. ATOH1 reinforces its own expression and directly regulates Dll1 and Dll4,
thus enabling Notch-dependent Atoh1 repression in neighboring cells; its subsequent activity
at primed cis-elements triggers numerous secretory genes. Sustained enhancer priming
allows ATOH1 activity or its absence, which respectively promotes or represses secretory
differentiation13, to affect the fate of specified cells, and DNA methylation also barely
changes as ISC differentiate30. True lineage commitment thus occurs late, if ever, in the
intestinal epithelium. Indeed, various stimuli revert differentiated cells into ISC with
surprising ease17,27,28, implying that the environment, and not some cell-intrinsic feature,
determines crypt cell potential. Broadly delineated enhancers likely underlie this remarkable
plasticity.
METHODS
Animals and drug administration
Mouse strains were purchased from The Jackson Laboratory or received as gifts and are
referenced in Extended Data Table 1. Mice, maintained under specific pathogen–free
conditions, were handled in accordance with protocols approved and monitored by the
Dana-Farber Cancer Institute Animal Care and Use Committee. Male and female C57BL/6
mice were used between 2 and 6 months of age. Dibenzazepine (DBZ, Syncom, Groningen,
The Netherlands) was suspended in 0.5% (w/v) hydroxypropylmethyl-cellulose (Methocel
E4M, Dow Chemicals) and 0.1% (w/v) Tween 80 (Bio-Rad) in water and 100 μmol/kg was
administered by intraperitoneal (IP) injection. We activated Cre-ER recombinase by IP
injection of 1 mg tamoxifen (Invitrogen) for 5 days or one dose of 4 mg tamoxifen. Cre-PR
recombinase was induced by 2 IP injections of 2 mg RU486 (Sigma) approximately 8 h
apart. BrdU (B-D Biosciences, 50 mg/kg) was injected IP and mice were sacrificed 1 h or 3
days later.
Cell isolation
Epigenomes were characterized in cells isolated from the first half of the small intestine.
LGR5+ ISC: Intestinal villi in Lgr5GFP-IRES-Cre mice10 were scraped away using glass
slides, crypt epithelium was collected by shaking in 5 mM EDTA for 50 min at 4°C, and
single-cell suspensions prepared by digestion in 4X TrypLE (Invitrogen) for 50 min at 37°C.
GFPhi (LGR5+) cells were sorted using a MoFlo instrument (Beckman Coulter). Sec-Pro
and GOB: Villi were scraped from intestines of wild-type mice 38 h after intraperitoneal
(IP) injection of DBZ (Syncom, 100 μmol/kg i.p.) and crypt cells isolated by shaking
residual, crypt-enriched tissue in 5 mM EDTA for 50 min at 4°C. RbpjFl/Fl;Villin-CreER
mice were injected with 2 daily IP doses of 2 mg tamoxifen, followed by isolation of crypt
Sec-Pro as above on the third day, or with 5 daily doses of 1 mg tamoxifen, followed by
Kim et al. Page 5
Nature. Author manuscript; available in PMC 2014 September 02.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tisolation of villus GOB on the 10th day. The latter were collected by shaking intestines
gently in 5 mM EDTA for 30 min at 4°C, followed by passage through 70 μm filters to
eliminate contaminating crypts. Ent-Pro and ENT: Crypt epithelial cells and mature ENT
were collected from Atoh1Fl/Fl;Villin-CreER intestines 14 days after tamoxifen treatment, as
described for other mice.
ChIP-seq and DHS-seq
For ChIP-seq, cells were fixed immediately in 1% formaldehyde with rotation for 25 min at
ambient temperature and lysed in 1% SDS, 10 mM EDTA, 30 mM Tris-HCl pH8, with
protease inhibitors (Roche). Lysates were sonicated using a Bioruptor instrument
(Diagenode) for 50 min with 30 s intervals and then incubated overnight at 4°C in dilution
buffer (1% Triton, 0.5 M EDTA, 5 M Nacl, 1 M Tris-HCl pH8, protease inhibitors) with
Dynabeads (Life Technologies) bound to H3K4me2 (Millipore 07-030), H3K27ac (Abcam
ab4729), or FLAG (Sigma F3165) antibodies. Beads were washed and cross-links were
reversed in 1% SDS in 0.1 M NaHCO3 for 8 h at 65°C. DNA was purified using quickPCR
spin kits (Qiagen) and libraries constructed using ThruPLEX-FD kits (Rubicon Genomics),
followed by deep sequencing on a HiSeq2000 instrument (Illumina). For DNaseI-
hypersensitive (DHS)-Seq, nuclei were isolated after incubation of epithelial cells on ice for
10 min in 0.2% NP-40 in a buffer containing 15 mM Tris-Cl pH 8.0, 15 mM NaCl, 60 mM
KCl, 1 mM EDTA, 0.5 mM EGTA, 0.5 mM spermidine, and 0.15 mM spermine. After
washing in the same buffer lacking spermidine and spermine, nuclei were digested with 25
U, 40 U or 50 U of DNase I (Roche) in digestion buffer (60 mM CaCl2, 100 mM NaCl, 10
mM CaCl2, 400 mM Tris-HCl) for 5 min at 37°C. Digestion was stopped by adding stop
buffer (50 mM Tris-HCl pH 8, 100 mM NaCl, 0.1% SDS, 100 mM EDTA), followed by
incubation for 2 h at 55°C with proteinase K (40 μg/ml). DNA was extracted using phenol-
chloroform and treated with 1 U RNase (Roche) for 30 min at 37°C. After gel purification of
50-100 bp DNA fragments, libraries were prepared using the ThruPLEX-FD kit (Rubicon
Genomics) and sequenced with Illumina HiSeq2000.
ChIP-Seq and DHS-Seq analyses
Sequence tags were aligned to the Mus musculus genome, build mm9 and uniquely mapped,
non-redundant reads were retained34,35. Genomic profiles of DNaseI hypersensitivity (DHS)
and histone marks or ATOH1 binding sites were generated using Model-Based Analysis of
ChIP-seq 2 (MACS2), with a q-value (false discovery rate, FDR) threshold of 0.01 and
default parameters36,37. Peaks were refined by requiring >5-fold enrichment in comparisons
with input DNA for ChIP-seq and local backgrounds for DHS-seq. For analyses centered on
ChIP peaks, non-promoter (>2 kb upstream or <1 kb downstream from any TSS) peaks from
all study samples were merged to create a union set. Read densities (in reads per 1M tags
within fixed, 200-bp bins, RPM) were calculated by normalizing counts in each peak region
in the union set based on sample sequencing depth. Meta-analyses around ATOH1 binding
sites were performed in the Cistrome pipeline38. Genomic wiggle traces were normalized for
sample sequence depth. Similarities among H3K4me2-marked enhancers in different cell
types were determined by hierarchal clustering using Spearman's rank correlation.
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tExpression analyses and correlation with Atoh1 occupancy
RNA was extracted from LGR5+ ISC, Sec-Pro, Ent-Pro, GOB and ENT with Trizol
(Invitrogen) and RNeasy Mini Kits (Qiagen), processed, and hybridized to Mouse Genome
430A 2.0 microarrays (Affymetrix). Data quality was verified using Affy QC Report in R
bio-conductor. mRNA profiles were analyzed by RMA to normalize expression indices39,
and differential expression across cell types was identified using LIMMA40 by F test with p
<0.002. Values in the expression heatmap (Extended Data Fig. 3) were normalized by
magnitude normalization and cell-type specificity was determined by k-means clustering of
differentially expressed genes. ATOH1 binding at enhancers was used as a function to
determine if ATOH1 activates Sec-Pro-specific genes. Each ATOH1 enhancer (>2 kb
upstream or <1 kb downstream from a TSS) was assigned to a nearby gene (TSS <20 kb
from an ATOH1 summit). After normalization of tags for sequence depth and peak width,
the sum of tag densities for each gene was used to measure its correlation with differential
expression.
Histology, immunohistochemistry, and immunofluorescence
Mouse jejuni (middle 1/3 of the small intestine) were fixed overnight in 4%
paraformaldehyde at 4°C and embedded in paraffin. Rehydrated 5 μm sections were stained
with Alcian blue (Sigma) and nuclear fast red (Sigma). For immunohistochemistry, antigens
were retrieved in 10 mM sodium citrate buffer (pH 6). Tissue sections were permeabilized
with 0.5% Triton X-100 (Sigma), blocked with 5% fetal calf serum (Gibco), incubated with
Ki67 (Vector Laboratories clone MM1, 1:1000), BrdU (AbD Serotec, 1:300), or ATOH1
(gift from Dr. J. Johnson, 1:500) antibodies, and washed in phosphate-buffered saline.
Sections were incubated with biotin-conjugated anti-mouse, rat or rabbit IgG (Vector
Laboratories, 1:300) and colors developed with Vectastain avidin-biotin complex (Vector)
and diaminobenzidine substrate (Sigma). ATOH1 immunostaining was enhanced with the
Tyramide Signal Application kit (Perkin-Elmer). For immunofluorescence, tissues
embedded in Optimal Cutting Temperature compound (Sakura) were sectioned and
incubated with Chromogranin A (ImmunoStar, 1:200), Mucin2 (Santa Cruz, 1:200), or TFF3
(gift from Dr. D. Podolsky, 1:500) antibodies. After washings, samples were incubated with
Alexa Fluor 594-conjugated anti-rabbit IgG (Invitrogen). In the lineage conversion
experiments in Atoh1Cre-PR/Fl;Rosa26YFP mice (Fig. 4p-s), tissue sections were stained
sequentially with Tff3 Ab and AP substrate.
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Extended Data Figure 1. Isolation of ISC and other intestinal cells
(a) Crypt-villus unit structure and components of crypt lateral inhibition. Terminally
differentiated enterocytes and secretory cells line intestinal villi and depend on self-
renewing crypt populations of LGR5+ ISC, bipotential (Bi-Pro), and specified secretory
(Sec-Pro) and enterocyte (Ent-Pro) progenitors. Stochastic ATOH1 expression in one Bi-Pro
induces secretory differentiation and Delta ligand expression, allowing Notch signal delivery
to neighboring cells, which use HES1 to repress Atoh1 and become enterocytes. (b)
Intestinal epithelial cell isolation strategies. LGR5+ ISC were isolated from Lgr5GFP-CreER
mice10; Sec-Pro and GOB were isolated from Rbpj−/− intestines7; additional Sec-Pro were
collected from DBZ-treated wild-type mouse crypts; Ent-Pro and ENT were harvested from
Atoh1−/− intestines14. (c) Crypt cells expressing high LGR5/GFP were isolated by flow
cytometry and pooled from 12 mice. Gates to distinguish GFPhi ISC from their GFPlo and
GFP− progeny are shown in the representative scatter plot. (d, e) Alcian blue staining of
Atoh1−/− intestines at low (d) and high (e) magnification, demonstrating global absence of
GOB. Inset in e shows the boxed region at higher magnification. (f) RbpjFl/Fl;Villin-CreER
intestines rendered null for Notch activity 6 days after tamoxifen injection, showing severe
goblet cell metaplasia, comparable to DBZ-treated wild-type intestines (See Extended Data
Fig. 2d). Scale bars, 50 μm. Duplicate samples were examined from 3 (Rbpj−/−) or 7
(Atoh1−/− ) mice.
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tExtended Data Figure 2. Enrichment of Sec-Pro by chemical inhibition of Notch signaling
(a) Quantitative RT-PCR data showing peak Atoh1 expression ~38 h after treatment of wild-
type mice with dibenzazepine (DBZ). (b-d) Low magnification views show no increase in
mature, Alcian blue-avid goblet cells 38 h after DBZ treatment (b), appearance of goblet
cells in villus bases and crypts 72 h after DBZ treatment (c), and migration of these cells to
occupy villi almost fully within 6 days (d). Inset in b shows a magnified view of the boxed
area. (e) Within 72 h of DBZ treatment, crypt cells virtually cease to replicate (e-E), retain
ATOH1 (e-C), and stain with Alcian blue (e-A), a sign of GOB maturation. By 120 h after
DBZ exposure, these ATOH1+ post-mitotic GOB occupy short villi (e-B,D,F). Scale bars,
50 μm. Tissue analyses were done in duplicate on 7 (DBZ+38h) or 3 (DBZ+72h, (DBZ
+144h) mice.
Extended Data Figure 3. Distinct expression profiles in LGR5+ ISC, Sec-Pro, Ent-Pro, and villus
enterocytes
Differential transcripts in purified intestinal cell types, arranged by K-means clustering of
normalized expression values from Affymetrix microarrays. Representative known genes in
each cell type are listed alongside the Gene Ontology functions most enriched in each group
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t(false discovery rates in parentheses), determined using Gene Set Enrichment Analysis tools
(http://www.broadinstitute.org/gsea/msigdb/annotate.jsp).
Extended Data Figure 4. Summary of ChIP-seq and DHS-seq experiments
(a) Summary of sites identified by MACS II in ChIP-Seq and DHS-Seq data from intestinal
cell populations. (b) Distribution of sites marked in promoters (<2 kb upstream or <1 kb
downstream of any TSS), coding regions, introns, and intergenic regions. (c) Correlation
analysis with Spearman's rank coefficient (left) and sample traces (right) of H3K4me2-
marked enhancers in independent ChIP-Seq replicates of Ent-Pro, showing very high
concordance. (d) H3K4me2 ChIP-seq profiles at arbitrarily selected regions of mouse
chromosome 17 illustrate the highly concordant signals in Sec-Pro produced by Rbpj loss
(top traces) or DBZ treatment (bottom traces), as heatmaps and clustering analysis (Fig. 2a-
b) demonstrate throughout the genome.
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tExtended Data Figure 5. Accessible, marked enhancers in intestinal crypt progenitors
(a-b) ChIP-seq and DHS-seq traces at sample secretory loci illustrate selective intron
marking in GOB at Tpsg1 (a), representing the profiles in Group 2 enhancers (Fig. 2a), and
highly similar distribution of H3K4me2, H3K27ac, and DHS signals (within dotted,
asterisked lines) across cell populations at Foxa1 (b), representing the prevalent Group 1
pattern. (c) Heatmaps of DHS at 116,324 to 139,312 enhancers showing accessible
chromatin in Sec-Pro and Ent-Pro, compared to DNAseI insensitivity at the same sites in
adipocytes, cardiac, and skeletal muscle (data from the ENCODE Project Consortium, PLoS
Biol 9, e1001046 (2011)), and lack of chromatin access in crypt progenitors at enhancers
that are active in these heterologous cells. (d) At a few secretory loci, such as Spdef, signs of
enhancer activity and access are higher in Rbpj−/− Sec-Pro or GOB than in other intestinal
cells. Asterisked intervals mark ATOH1 binding regions.
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tExtended Data Figure 6. ATOH1 transcriptional control of secretory differentiation
(a) Model for cell-specific ATOH1 binding to permissive chromatin in crypt progenitors. (b)
Phastcons plot showing high evolutionary conservation of ATOH1-occupied sites in Sec-Pro
and maximal enrichment of the consensus ATOH1 recognition motif near their peaks. (c)
Composite profiles of average H3K4me density near ATOH1 binding sites in Sec-Pro (left)
and mouse brain (right). H3K4me marks are highly correlated with ATOH1 occupancy in
the same, but not in the heterologous, tissue, as representative ChIP-seq data illustrate
below. (d-e) Examples of ATOH1 occupancy at loci for key secretory lineage TFs and
secretory-specific genes: Nkx2-2 and Foxa2 (enteroendocrine cells), Xbp1 (Paneth cells),
Tff3 (goblet cells), Spink4 and Hgfac (goblet and Paneth cells) and Sstr1 (endocrine cells).
ATOH1 does not bind near Ent-Pro-specific genes, as shown at a sample locus, Bcl2l15. (f)
Schematic representation of ATOH1's dual function in direct control of two gene groups:
Delta ligands for lateral inhibition and key secretory-specific TFs to promote secretory
lineage differentiation. (g) Relation of ATOH1 occupancy at enhancers with Sec-Pro-
specific transcription. Bins of 200 genes, ranked by differential expression in Sec-Pro (left)
or Ent-Pro (right), are represented along the x-axis and normalized ATOH1 binding in Sec-
Pro (red) or brain (blue) at enhancers within 20 kb of the genes in each bin is represented on
the y-axis. The graphs show the first (Sec-Pro-specific), middle (no differential expression),
and last (Ent-Pro-specific) 3 bins of 200 genes each. Pair-wise T tests support a role for
ATOH1 in activating Sec-Pro genes, without an overt role in silencing Ent-Pro genes.
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tExtended Data Figure 7. ATOH1 binding at H3K4me2-marked enhancers
Representation of ATOH1 binding sites in relation to the heatmap of H3K4me2 marking at
57,481 non-promoter sites (from Fig. 2a), showing that ATOH1 occupies an abundance of
sites marked in all crypt populations. Only in mature villus cells does ATOH1 preferentially
bind enhancers that are selectively marked in GOB.
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tExtended Data Figure 8. ATOH1-dependent lineage conversion
(a-d) BrdU tracing 1 and 3 days after label injection, showing similar turnover of intestinal
epithelial cells in wild-type and Atoh1-null intestines in the absence of Notch inhibition.
Nearly all the label is in the villus base at 1 day and in the top halves of villi at 3 days. (e)
Lineage tracing 3 days after induction of Cre activity by tamoxifen in Lgr5Cre-ER;Rosa26YFP
mice (left) or by RU486 in Atoh1Cre-PR;Rosa26YFP mice (right). YFP is detected in
numerous whole crypts (except Paneth cells) in the former, and never in crypts, ribbons or
cell pairs in the latter, confirming absence of leaky CrePR expression in multipotent
progenitors. (f) YFP signal in Atoh1Cre-PR;Rosa26YFP mice 3 days after RU486-induced Cre
activation is confined to scattered ChgA+ enteroendocrine and Muc2+ GOB cells. (g) Two
additional representative examples of YFP-traced cell groups that had converted into Tff3-
negative ENT after Atoh1 deletion in secretory cells. Arrows indicate rare (~5%, see text)
YFP+ cells that still express Tff3. Scale bars, 50 μm. Tissues were analyzed in duplicate
from 4 (Wt, Atoh1−/−, AtohCre-PR/+;Rosa26YFP) or 6 (Lgr5Cre-ER;Rosa26YFP) mice.
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tExtended Data Table 1
Mouse strains used in this study.
Mouse strain Features Application in our study Ref.
Lgr5GFP-IRES-Cre(ER-T2) Knock-in of a GFP-Cre fusion transcript
into the Lgr5 locus, creating a null, GFP-
expressing Lgr5 allele while retaining
one wild-type allele
To isolate GFP+ (LGR5+) ISC by flow
cytometry
10
Atoh1FLAG FLAG epitope-tagged Atoh1 allele
created by gene knock-in
ATOH1 ChIP-seq using FLAG antibody 25
Atoh1Cre-PR Progesterone-inducible Cre recombinase
knocked in to the Atoh1 locus, creating
one null Cre-expressing and retaining one
wild-type allele
Specific, RU486-inducible Cre
activation in ATOH1-expressing crypt
epithelial cells, to monitor their fate
following Atoh1 deletion (Fig. 4)
29
AtohFl Conditional (floxed) Atoh1 allele that is
rendered null by Cre-mediated
recombination
Intestinal depletion of ATOH1 to
eliminate all secretory cells, and hence
isolate Ent-Pro from crypts and pure
mature enterocytes from villi
14
RbpjFl Conditional (floxed) Rbpj allele that is
rendered null by Cre-mediated
recombination
Alternative, genetic strategy to DBZ-
induced Notch inhibition. Induction of
total secretory metaplasia to allow
isolation of Sec-Pro from crypts and
pure mature goblet cells from villi
31
Villin-Cre(ER) Transgenic mice expressing Cre
recombinase selectively in all intestinal
epithelial cells, driven by endogenous
Villin promoter and enhancer elements
To express tamoxifen-responsive Cre
recombinase throughout the intestinal
epithelium in adult mice
32
Rosa26Lox-STOP-LoxYFP Knock-in of Cre recombinase-dependent
eYFP cDNA in the ubiquitously
expressed, non-essential Rosa26 locus
To trace ATOH1-expressing crypt cells
to follow their choice of secretory vs.
enterocyte fate (Fig. 4)
33
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Enrichment of Sec-Pro and Ent-Pro
Approximately 38 h (DBZ treatment) or 3 days (Rbpj loss) after Notch inhibition, crypt cells
remain proliferative (n,o) but express ATOH1 (h,i) and fail to stain with Alcian blue (b,c),
indicating immaturity. By 4 days after Rbpj deletion, crypt cells cease replication (p), retain
ATOH1 (j), and show weak Alcian blue staining (d); 2 days later, their GOB progeny
occupy short villi (e,k,q). Atoh1−/− intestines lack secretory cells, carrying only ENT on villi
(f) and replicating ATOH1− Ent-Pro in crypts (l,r). Scale bars, 50 μm. Duplicate samples
were examined from 3 (Rbpj−/− and WT ) or 7 (DBZ+38h and Atoh1−/−) mice.
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tFigure 2. Broadly permissive chromatin in intestinal crypt progenitors
(a) H3K4me2 levels at 57,481 sites (>2 kb upstream or >1 kb downstream of any TSS) are
similar in Sec-Pro, Ent-Pro, and LGR5+ ISC; Sec-Pro-selective genes are usually marked as
strongly in other cells as in Sec-Pro. Groups 1a and 2 denote strongly marked and unmarked
enhancers, respectively, in Sec-Pro. Group 1b denotes enhancers with superficially stronger
marking in one or other progenitor. (b) Hierarchal clustering and Spearman's correlation
coefficients for normalized H3K4me2 signals in crypt and villus enhancers. Crypt and villus
cells show expected differences, but crypt progenitors and ISC are highly similar. (c)
H3K27ac and DHS levels at 21,354 enhancers with robust H3K4me2 in Rbpj−/− Sec-Pro.
Many sites show high H3K27ac and DHS, both similar in Sec-Pro and Ent-Pro. (d) High
concordance, shown with Spearman's correlation coefficients, between all sites with
H3K27ac (33,257 sites) or DHS (116,325 sites) in Sec-Pro and Ent-Pro.
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tFigure 3. ATOH1 binding and chromatin interactions
(a) Low overlap of ATOH1 binding sites in mouse Sec-Pro and brain. (b) ChIP-seq data
showing multiple strong ATOH1 binding sites at Sec-Pro-selective Atoh1, Dll1 and Dll4
genes (left) and at crucial TF genes expressed specifically in Sec-Pro (right). (c) Average
H3K4me2, H3K27ac, and DHS signals at ATOH1-bound enhancers are comparable in
intestinal crypt cell populations, including Atoh1-null Ent-Pro. Intestinal DHS sites differ
from those in other tissues. (d) Data at a representative secretory locus show similar
H3K4me2, H3K27ac, and DHS levels in all crypt populations, including at ATOH1-bound
enhancers (asterisks and dotted lines).
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tFigure 4. Conversion of specified secretory cells to enterocytes
(a) Notch inhibition (DBZ, 2 doses 6 h apart) and ATOH1 depletion schema in
Atoh1Fl/Fl;Villin-CreER mice, with BrdU tracing. (b-g) Three days after Notch inhibition (1
h post-BrdU), most ATOH1-depleted crypt cells showed BrdU and little Alcian blue
staining; Cre− crypt cells had largely stopped replicating and started to mature into GOB. (h,
i, l, m) Six days after Notch inhibition (3 days post-BrdU), ATOH1-depleted cells had
converted globally to enterocytes, showing alkaline phosphatase (AP) but not Alcian blue
staining; ATOH1+ control intestines showed profound goblet cell metaplasia. (j, k, n, o)
BrdU, absent in Atoh1Fl/Fl;Cre− intestines, appeared at villus tips in Atoh1Fl/Fl;Villin-CreER
intestines. Boxes (c, f, j, n) are magnified in adjacent panels. (p) Notch inhibition and Sec-
Pro-selective Atoh1 deletion strategy in Atoh1Cre-PR/Fl;Rosa26YFP mice. (q-s) Ribbons of
crypt cells originally specified as secretory (YFP+) and then rendered Atoh1-null expressed
AP but not GOB marker Tff3. The box in q is magnified in r and s; arrows point to rare
YFP+ Tff3+ cells. Scale bars, 50 μm. Duplicate samples were examined from 3 (Cre-: DBZ
+72h, DBZ+144h), 9 (Villin-Cre, DBZ+72h), 6 (Villin-Cre, DBZ+144h), or 4
(AtohFl/Cre-PR) mice.
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